Pharmacology of Parsabiv® (etelcalcetide, ONO-5163/AMG 416), a novel allosteric modulator of the calcium-sensing receptor, for secondary hyperparathyroidism in hemodialysis patients-Reference-Cited by-同舟云学术

Pharmacology of Parsabiv® (etelcalcetide, ONO-5163/AMG 416), a novel allosteric modulator of the calcium-sensing receptor, for secondary hyperparathyroidism in hemodialysis patients

Published:2019-01 Issue: Volume:842 Page:139-145
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Harada Kazutsune,Fujioka Aiko,Konno Masakazu,Inoue Atsuto,Yamada Hiroyuki,Hirota Yasushi

Publisher

Elsevier BV

Subject

Pharmacology

Reference28 articles.

1. Critical cysteine residues in both the calcium-sensing receptor and the allosteric activator AMG 416 underlie the mechanism of action;Alexander;Mol. Pharmacol.,2015

2. Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism;Behets;Kidney Int.,2015

3. Effect of etelcalcetide vs cinacalcet on serum parathyroid hormone in patients receiving hemodialysis with secondary hyperparathyroidism: a randomized clinical trial;Block;JAMA,2017

4. Parathyroid gland regulation: contribution of the in vivo and in vitro models;Carrillo-López;Expert Opin. Drug Discov.,2010

5. Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options;Cunningham;Clin. J. Am. Soc. Nephrol.,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glutathione-Based Photoaffinity Probe Identifies Caffeine as a Positive Allosteric Modulator of the Calcium-Sensing Receptor;ACS Chemical Biology;2024-07-08

2. KMT2A and chronic inflammation as potential drivers of sporadic parathyroid adenoma;Clinical and Translational Medicine;2024-06

3. Calcimimetic AMG-416 induced short-term changes in calcium concentrations and calcium isotope ratios in rats;Biochemical and Biophysical Research Communications;2023-10

4. Pharmacological profile of upacicalcet, a novel positive allosteric modulator of calcium-sensing receptor, in vitro and in vivo;European Journal of Pharmacology;2023-10

5. Progress in the Treatment of Secondary Hy-perparathyroidism;Advances in Clinical Medicine;2023